Importing and exporting biological samples to and from a US bioanalytical lab requires the US government’s oversight to prevent the transportation of exotic diseases and the supplying of illegal markets. Pharma companies and bioanalytical partners must proactively work together to secure the correct import or export licenses or permits prior to shipment to ensure international samples arrive intact and on time. In this webcast, learn more about how the process is navigated to help you successfully plan your study’s timeline and avoid compromising your samples in transit.
